News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Hemostemix Announces $2,725,982 Update to Second Closing
December 3, 2024
·
6 min read
Press Releases
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
December 3, 2024
·
4 min read
Press Releases
First Patient Treated with Adaptimmune’s TECELRA(R) (afamitresgene autoleucel)
December 3, 2024
·
10 min read
Press Releases
Marvel Biosciences Announces Promising New Data from Rett Syndrome Study and Plans to Discuss Orphan and Rare Disease Status with the FDA
November 26, 2024
·
5 min read
Press Releases
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Release New Study on Bioregenerative Blueprint for Athletic Longevity
November 26, 2024
·
6 min read
Press Releases
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
November 21, 2024
·
3 min read
Press Releases
Marvel Biosciences Secures $300,000 Grant to Advance Groundbreaking Alzheimer’s Research
November 21, 2024
·
5 min read
Press Releases
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
November 21, 2024
·
5 min read
Press Releases
Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)
November 19, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
November 19, 2024
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us